SOD1 transgenic models show different features of the ALS pathology, such as the progressive loss of motor neurons, axonal and mitochondrial dysfunction, progressive motor paralysis, muscle atrophy, and reduced lifespan [40–42]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.